EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 162 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,022,083 | -9.3% | 191,635 | +11.8% | 0.01% | 0.0% |
| Q2 2023 | $3,332,618 | -47.2% | 171,431 | -22.9% | 0.01% | -50.0% |
| Q1 2023 | $6,310,339 | +43.3% | 222,430 | +47.7% | 0.01% | +25.0% |
| Q4 2022 | $4,402,856 | +89.0% | 150,628 | +70.8% | 0.01% | +100.0% |
| Q3 2022 | $2,329,000 | -74.8% | 88,172 | -57.6% | 0.00% | -73.3% |
| Q2 2022 | $9,248,000 | -25.8% | 208,169 | -17.4% | 0.02% | -6.2% |
| Q1 2022 | $12,470,000 | -11.0% | 251,979 | -8.5% | 0.02% | 0.0% |
| Q4 2021 | $14,018,000 | – | 275,305 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 400,000 | $5,732,000 | 1.52% |
| Park West Asset Management LLC | 426,900 | $6,117,000 | 0.80% |
| WALL STREET ASSOCIATES | 200,000 | $2,866,000 | 0.25% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 284,653 | $4,079,000 | 0.16% |
| FARALLON CAPITAL MANAGEMENT LLC | 100,000 | $1,433,000 | 0.02% |
| NEXT Financial Group, Inc | 2,500 | $26,000 | 0.01% |
| PIPER SANDLER & CO. | 1,277 | $18,000 | 0.01% |
| Ground Swell Capital, LLC | 400 | $6,000 | 0.01% |
| PARADIGM ASSET MANAGEMENT CO LLC | 6,300 | $90,279,000 | 0.01% |
| Paloma Partners Management Co | 14,363 | $206,000 | 0.01% |